Insight Molecular Diagnostics (IMDX) EBT Margin Growth (1y) (2021 - 2026)
Insight Molecular Diagnostics (IMDX) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 30.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 617.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 163.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 665.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -115.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 113.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -646.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 288.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -37.00 |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | -3.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.48 Mn |
| Dec 31, 2025 | 19,530.00 |
| Sep 30, 2025 | 478,224.00 |
| Jun 30, 2025 | 336,778.00 |
| Mar 31, 2025 | 482,108.00 |
| Dec 31, 2024 | 281,130.00 |
| Sep 30, 2024 | -621,350.00 |
| Jun 30, 2024 | -319,541.00 |
| Mar 31, 2024 | -719,333.00 |
| Dec 31, 2023 | -479,174.00 |
| Sep 30, 2023 | 120,085.00 |
| Jun 30, 2023 | -122,426.00 |
| Mar 31, 2023 | 233,331.00 |
| Dec 31, 2022 | 69,590.00 |
| Sep 30, 2022 | -131,099.00 |
| Jun 30, 2022 | 2,974.00 |
| Mar 31, 2022 | 69,470.00 |
| Dec 31, 2021 | 28,873.00 |
| Sep 30, 2021 | -18,028.00 |
| Jun 30, 2021 | 576,396.00 |